Article

360 Network | THE GUIDE | May 1, 2009

360 Network

Click here to view a 360 Guide from a past issue of Urology Times.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Medical stethoscope and dollar bills | Image Credit: © Kuzmick - stock.adobe.com
TMT for bladder cancer: Balancing cost and quality of life
Anne Schuckman, MD, outlines current challenges in NMIBC care
Anne Schuckman, MD, outlines current challenges in NMIBC care
1 expert is featured in this series.
Managing Abiraterone Intolerance: Alternative Dosing Strategies in Practice
1 expert is featured in this series.
Decision-Making and Multidisciplinary Counseling for Nodal Involvement on PSMA PET
Justin Dubin, MD, on the use of AI in the male infertility space
Justin Dubin, MD, on the use of AI in the male infertility space
Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
Daniel D. Joyce, MD, MS, answers a question during a Zoom video interview
Investigators compare trimodal therapy vs cystectomy in MIBC
Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
In the Pipeline: Novel Treatment Delivery Methods for NMIBC
In the Pipeline: Novel Treatment Delivery Methods for NMIBC
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
Investigators assess ctDNA’s role in NMIBC
Related Content
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
July 8th 2025

UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC

Benjamin P. Saylor Hannah Clarke
According to the company, the MHRA approval represents the first marketing approval outside the US for NAI.
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD
Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
July 8th 2025

Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC

Hannah Clarke
The data, collected as part of the phase 1/2 Duravelo-1 trial, showed an objective response rate of 65%.
Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD
The conversation covers practical, case-based strategies for counseling MSM patients.
Expanded indication sought for niraparib plus AAP in Europe
July 7th 2025

Expanded indication sought for niraparib plus AAP in Europe

Hannah Clarke
The application is supported by data from the phase 3 AMPLITUDE trial.
Regulatory recap: FDA approvals in urology from the first half of 2025
July 4th 2025

Regulatory recap: FDA approvals in urology from the first half of 2025

Hannah Clarke
Take a look through all the regulatory milestones in urology from the first half of the 2025.
© 2025 MJH Life Sciences

All rights reserved.